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Solid-state NMRThe membrane interactions of the antimicrobial peptides aurein 1.2 and caerin 1.1 were observed by 31P and 2H
solid-state NMR and circular dichroism spectroscopy. Both peptideswere relatively unstructured inwater. In the
presence of dimyristoylphosphatidylcholine (DMPC) and mixed DMPC and dimyristoylphosphatidylglycerol
(DMPG) vesicles, both peptides displayed a considerable increase in helical content with the shorter aurein pep-
tide having a higher α-helix content in both lipid systems. In ﬂuid phase DMPC vesicles, the peptides displayed
differential interactions: aurein 1.2 interacted primarily with the bilayer surface, while the longer caerin 1.1 was
able to penetrate into the bilayer interior. Both peptides displayed a preferential interactionwith theDMPG com-
ponent in DMPC/DMPG bilayers, with aurein 1.2 limited to interaction with the surface and caerin 1.1 able to
penetrate into the bilayer and promote formation of amixture of lipid phases or domains. In gel phase DMPC ves-
icles, aurein 1.2 disrupted the bilayer apparently through a carpet mechanism, while no additional interaction
was seen with caerin 1.1. Although a lamellar bilayer was retained with the mixed DMPC/DMPG vesicles
below the phase transition, both caerin 1.1 and aurein 1.2 promoted disruption of the bilayer and formation of
an isotropic phase. The peptide interaction was enhanced relative to the ﬂuid phase and was likely driven by
co-existence of membrane defects. This study thus demonstrates that the effects of the lipid phase and domains
need to be considered when studying membrane interactions of antimicrobial peptides.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Aurein 1.2 (GLFDIIKKIAESF-NH2) and caerin 1.1 (GLLSVLGSVAKHV
LPHVVPVIAEHL-NH2) are two antimicrobial peptides (AMP) expressed
in the skin secretions of the Litoria genus of Australian tree frogs [1–6].
Both peptides are cationic and fold into amphipathic α-helices on
partitioning into membrane mimetic environments [3,7,8]. Each pep-
tide has been shown to be active towards numerous micro-organisms
[6] as well as possessing anticancer [1,3,9] and antiviral [10,11]
activities.
Previous studies conducted on these and other related peptides re-
port that they likely exert their mode of action through direct interac-
tion with and perturbation of the bacterial membrane [1,7,12–15].
Two principal modes of action have been proposed [16,17]: transmem-
brane pore formation across the membrane by either a barrel-stave
[17,18] or toroidal pore [19]; or a carpet mechanism where the mem-
brane is lysed in a detergent-like manner [16–18,20]. Aurein 1.2 with
13 residues is too short to fully span a typical phospholipid bilayer as
an α-helix and we have previously shown that it acts via the carpet
mechanism of membrane lysis [21]. By contrast, caerin 1.1 with 25+61 3 9347 8159.
rights reserved.residues would be able to fully span a membrane bilayer as an α-helix
and may act via a pore formation mechanism or even the carpet
mechanism.
As part of a larger family of related frog AMPs, both show an in-
creased afﬁnity for anionic membrane systems [15,22], which has
been recognised as an important determinant for activity towards
micro-organisms. Biological membranes are heterogeneous and vary
in composition between species, and as a function of growth cycle and
environmental conditions, so model membranes have been chosen to
mimic some of the desired characteristics of eukaryotic and prokaryotic
membranes. Phosphatidylcholine (PC) lipids are common within eu-
karyotic organisms [23,24] while, despite variations between species,
bacterial membranes tend to contain lipids with anionic headgroups
that are effectively mimicked by phosphatidylglycerol (PG) [25]. Yet
with many systems, the speciﬁc lipid phase present has been shown
tomodulate peptide–membrane interactions. AMP studies have usually
focussed on the use of ﬂuid (Lα) phase lipid membranes but certain
antimicrobial peptides, such as magainin 2, maculatin 1.1 [26] and the
membrane-lytic peptide melittin, have been shown to have enhanced
interactions with gel phase lipid systems [26–33].
However, studies of AMP–membrane interactions have usually con-
centrated on the effects of membrane charge on mediating peptide–
lipid interaction rather than other structural features such as the lipid
phase. Also, despite studies showing that features present in mixed
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promote peptide interaction [29,33–35], peptide interactions are com-
monly investigated using ﬂuid lamellar bilayers. Several studies have
been conducted with aurein 1.2 and caerin 1.1 showing that they act
via different modes of interaction. However, the interaction has some-
times been observed to differ between measurement techniques such
as quartz crystal microbalance with dissipation (QCM-D) [36] and
dual polarisation interferometry (DPI) [37] using gel phase bilayers
and those conducted in the ﬂuid phase such as NMR [38]. Therefore,
the effects of the lipid membrane phase on antimicrobial action re-
quired further investigation. In this study we compared and contrasted
the mode of action of aurein 1.2 and a larger related AMP, caerin 1.1,
which is capable of spanning a membrane bilayer and may act via a
pore-forming mechanism. The peptide secondary structure was deter-
mined by circular dichroism (CD) spectroscopy and the interactions
withmembranes above and below the gel–ﬂuid transition temperature
were examined with 2H and 31P NMR spectroscopy.
2. Materials and methods
2.1. Preparation of peptide–lipid NMR samples
Perdeuterated-acyl chaindimyristoylphosphatidylcholine (d54-DMPC)
and natural abundance dimyristoylphosphatidylglycerol (DMPG) were
purchased fromAvanti Polar Lipids (Alabaster, AL, USA), and usedwith-
out further puriﬁcation. Aurein 1.2 and caerin 1.1 were obtained from
Mimotopes (Melbourne, Australia) with purity of >90%. HCl solution
(5 mM) was added before each peptide was lyophilised to ensure that
any traces of triﬂuoroacetic acid were removed [39]. Pure d54-DMPC
and mixed d54-DMPC/DMPG (2:1 mole ratio) lipid systems were
prepared as described below and peptide added at 10:1 lipid/peptide
(L/P) molar ratio. Typically 1 mg of peptide and 4 mg of phospholipid
were used.
Phospholipids were dissolved in chloroform/methanol (~9:1 v/v)
and a rotary evaporator used to form a thin ﬁlm before samples were
placed under a high vacuum overnight to remove trace amounts of
solvent. Dried lipid thin ﬁlms were hydrated with typically 500 μL of
Milli-Q water before being lyophilised. The dried samples were
re-hydrated with typically 100 μL of 10 mMMOPS (3-(N-morpholino)
propanesulfonic acid) buffer pH 7, with or without dissolved peptide,
and subjected to 5 cycles of freeze–thaw before being transferred into
5 mm NMR glass sample tubes.
2.2. Solid-state NMR experiments
Static deuterium and phosphorus spectra were acquired at four
temperatures: with the bearing air supply to the NMR probe set
to 30, 20, and 15 °C and then reheated to 30 °C. The NMR probe
containing the samples was removed from the magnetic ﬁeld be-
tween each temperature change and allowed to equilibrate for a min-
imum of 1 h and then allowed to equilibrate within the magnet for
15–20 min before spectra were collected.
2H spectra were carried out at 46.09 MHz on a Varian Inova-300
spectrometer (Palo Alto, USA) with 5 mm HX probe using a composite
pulse solid echo sequence [40]. Operating conditions included 4.1 μs
90° pulses, 40 μs echo delay and 0.5 s recycle time. Typically 20 K
scans were collected and Fourier transformed using zero-ﬁlling to
16 K points with 200 Hz exponential line broadening. Oriented spectra
were generated by dePaking in the time domain using a recently devel-
oped in house nmrPipe macro (unpublished data, JD Gehman). The
dePaked spectrum was ﬁt with Gaussian lineshapes and converted to
order parameters by dividing the static splitting of each 26 myristoyl
CD2 position with the static coupling constant of 168 kHz [41].
31P solid-state NMR experiments were performed at 121.543 MHz
on a Varian Inova-300 spectrometer (Palo Alto, USA) with 5 mm HX
probe using a Hahn echo pulse sequence with 50 kHz protondecoupling [42]. Typically 4.4 μs 90° pulse was used with 29 μs echo
time and 3 s recycle delay. A minimum of 20 K scans was collected
and processed with 100 Hz exponential line broadening and zero
ﬁlling to 8 K points. Static 31P NMR spectra were deconvoluted as pre-
viously described [43].
2.3. Circular dichroism (CD) spectroscopy
For CD studies, DMPC and DMPC/DMPG (2:1) were dissolved in
chloroform/methanol (2:1) and peptides were dissolved in methanol
(1 mg/mL) and appropriate amounts were added to a 10 mL pear
shaped ﬂask before removal of solvents by rotary evaporation to afford
lipidﬁlmswith andwithout peptide. Lipidﬁlmswere then placed under
high vacuum for 0.5 to 1 h. The lipid ﬁlm was suspended in 0.25 mL
Milli-Q water by brief vortex mixing and water bath sonication to give
a constant ﬁnal peptide concentration of 1 mg/mL and phospholipid/
peptide mole ratios of 15:1 and 100:1. The suspension was sonicated
brieﬂy at 30 °C until translucent prior to CD spectroscopy.
CD spectra were acquired on an Aviv spectropolarimeter (Lake-
wood, NJ, USA). Peptide solutions were loaded into a 0.1 mm Suprasil
quartz circular demountable cell (Hellma Ltd., UK) and spectra recorded
in the wavelength range from 280 nm to 180 nm with an interval of
1 nm, and an averaging time of 2 s. Sampleswere allowed to equilibrate
for 5 min at 30 °C prior to accumulating 3 scans. Similarly, baseline
spectra of lipids prepared in the same manner but without protein,
were obtained. Replicate sample and baseline spectra were averaged,
and the baseline subtracted from the averaged sample spectrum of
the lipid background; the resulting spectra were calibrated against a
spectrum of camphorsulfonic acid before conversion to units of mean
residue ellipticity using mean residue weight values of 113.7 and
103.3 for aurein and caerin, respectively. To estimate the peptide sec-
ondary structure content, analyses were carried out using the
DichroWeb analysis server [44]. The reference set SMP180 was used
[45] and analysis performed using the CONTIN/LL algorithm [46]. The
goodness of ﬁt parameter NMRSD was used for scaling and to assess
the quality of the ﬁt [47]. The CD spectra and associated metadata are
deposited in the Protein Circular Dichroism Data Bank as entries
CD0004066000 (caerin) & CD0004067000 (aurein).
3. Results
3.1. Secondary structure of aurein 1.2 and caerin 1.1 by CD
The conformational changes of aurein and caerin following associa-
tion with phospholipid bilayers were characterised using CD spectrosco-
py. Spectra were acquired at 30 °C, above the gel–liquid transition
temperature of the pure lipid systems [48]. The CD spectra and calculated
helical contents of aurein and caerin in water and membrane environ-
ments are shown in Fig. 1 and Table 1. In the absence of phospholipid
the peptides were largely unstructured, although aurein displayed
about 20% helical content.
At low lipid/peptide ratios similar to those used with NMR experi-
ments, zwitterionic DMPC caused a signiﬁcant increase (from 20% to
70%) in the helical content exhibited by aurein 1.2, whereas caerin
showed only a small increase in α-helix (from 8 to 20%). Possibly the
less charged shorter aurein is able to interact more with the PC bilayer
resulting in a more structured peptide. At the higher lipid/peptide ratio,
α-helical dominates the shorter peptide structure. The membrane mi-
metic environment promoted an α-helical secondary structure, which
is a typical feature of this class of compounds [1]. Caerin remained largely
unstructured although the α-helical content had increased (to ~40%).
When in the presence of the anionic mixed (DMPC/DMPG) lipid system,
both peptides becomemoreα-helical. However, theα-helical content as
determined by NMR in solvent ormicelles is higher [3,5] as NMR favours
the structured formwhereas CD is the average of the free andboundpep-
tide structures.
Fig. 1. CD spectra of aurein 1.2 (top) and caerin 1.1 (bottom) in water (solid line) and in
the presence of DMPC (15:1,—) and (100:1,…) andmixedDMPC/DMPG (2:1) (15:1,- - - )
and (100:1, - - -) normalised as MRE units; 3 scans accumulated at 30 °C.
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2H NMR spectra of acyl chain deuterated phospholipid bilayers
allow acyl chain order to be investigated, providing a tool to probe pep-
tide interactions occurringwithin themembrane. A perdeuterated lipid
acyl chain yields a spectrum with a complex lineshape (Pake powder
pattern) inwhich alterations in splittings (width) provide an indication
of changes in acyl chain order and packing [49]. Static 31P NMR of
unoriented phospholipid bilayers provides information on the lipid
phase as well as the local order and dynamics within the phosphate
region of the lipid [50]. Liquid lamellar (Lα) phospholipid liposomes
produce an axially symmetric powder pattern (chemical shift anisotro-
py, CSA) for which the overall width depends on the headgroup orien-
tation and dynamics [51]. The CSA is used here as the width of the
powder pattern. Hence a combination of 2H and 31P NMR experimentsTable 1
Secondary structures of aurein 1.2 and caerin 1.1 in DMPC and DMPC/DMPG (2:1)
vesicles based on CD spectroscopy. NRMSD is a goodness-of-ﬁt parameter between
the data and the calculated structure.
Sample P/L % α-helix % other NRMSD
Aurein/water – 21 79 0.160
Aurein/DMPC 1:15 74 26 0.079
1:100 48 52 0.119
Aurein/DMPC/DMPG 1:15 60 40 0.105
1:100 69 31 0.112
Caerin/water – 8 92 0.122
Caerin/DMPC 1:15 20 80 0.142
1:100 39 61 0.108
Caerin/DMPC/DMPG 1:15 43 57 0.024
1:100 61 39 0.050was performed to determine the effects of aurein 1.2 and caerin 1.1 on
phospholipid acyl chains and headgroup perturbations over a range of
temperatures. A high concentration of peptide (10:1 L/P) was used to
mimic the conditions underwhich peptides effectively lyse phospholipid
bilayers [21,37].
As reported previously [43], at 30 °C the d54-DMPC control sample
produced a typical ﬂuid phase 2H order parameter proﬁle, with rigidity
decreasing from the upper acyl chains down through the terminal
methyl region (Fig. S1). Addition of DMPG at a 33% molar ratio had no
signiﬁcant effect on the order of the DMPC acyl chains, as seen in similar
lipid systems [43,52,53]. The 31P spectra of DMPC and mixed DMPC/
DMPG vesicles (Fig. 2) consist of typical axially symmetric powder
patterns at 30 °C with a CSA of ~45 ppm for DMPC and the mixed
lipid system contained a merged CSA of both DMPC and DMPG of 40
and 31 ppm, respectively (Table 2). A small peak of ~1% intensity was
observed at the isotropic chemical shift position in the DMPC sample
which was likely caused by a small population of internal small
unilamellar vesicles (observed by cryo-TEM of NMR samples, Fig. S2).
The spectrum of the mixed system produced a narrower CSA, with the
DMPC component reduced by ~11%, indicating that the presence of
DMPG permits enhanced freedom of motion among the headgroups
or change in the orientation of the headgroup in response to the
charged surface [38].
In the presence of aurein 1.2, the order parameters of the upper acyl
chain of DMPC decreased by ~6% while the acyl chain closer to the
methyl was largely unchanged. An ~16% reduction in the 31P CSA was
also observed which together indicate an increase in disorder or free-
dom of motion among the upper chain region and headgroup, with
minimal interaction with the bilayer interior. Although the 31P CSA
was reduced by ~16%with caerin 1.1, by contrast, the order parameters
of the DMPC upper acyl chain region increased by between 3 and 4%
while the lower acyl chain was more disordered by between 3 and
10%; which suggested peptide interaction with the surface and entire
depth of the bilayer interior. The increased resolution of the splittings
reﬂects an ordering of the lipid acyl chains by caerin in DMPC at 30 °C.
A more complex interaction was observed with the mixed
d54-DMPC/DMPG bilayers (Fig. 3) at 30 °C. Addition of aurein 1.2
caused a reduction of between 3 and 5% in the order parameters of
the full length of the acyl chain and two 31P CSAs (Fig. 4a) were re-
solved, with a large reduction in the linewidth (~38%) of the minor
(DMPG) component. The proportions of signal did not change signiﬁ-
cantly from their initial ~2:1 value, suggesting that the peptide interac-
tion was primarily with the anionic DMPG.
Caerin 1.1 had amuchmore pronounced effect on the anionic bilay-
er at 30 °C with formation of a complex mixture of isotropic, gel and
ﬂuid lamellar bilayer 2H spectra. The major (DMPC enriched) 31P CSA
component (Fig. 5a) increased slightly by 2 ppm while the minor
(DMPG enriched) component CSA decreased by 5–6 ppm. The propor-
tions of signal in each changed signiﬁcantly, with the DMPC component
reducing from ~68 to 36% of the signal while the DMPG reduced from
32 to 11%. A large peak at the isotropic chemical shift was formed that
contributed 53% of the signal and indicated severe bilayer disruption.
The increase in the CSA of the major component closer to that of pure
DMPC and the decrease in CSA of the minor component, suggest a pref-
erential interaction with the anionic lipid. This was supported by the
DMPG component signal reducing by ~65% compared with 47% for
the DMPC component, which implies that the large isotropic phase
was enriched in DMPG. It is likely that multiple domains were formed
with the peptide incorporation inducing areas of both reduced and
enhanced lipid order.
3.3. Effect of temperature and lipid phase on peptide interaction
Reducing the temperature just below the gel–ﬂuid phase transition
of the pure lipid systems [48] to 20 °C produced 2H spectra characteris-
tic of restricted acyl chain motion while the DMPC 31P spectra (Fig. 2),
Fig. 2. 31P (1st, 3rd column) and 2H (2nd, 4th column) NMR spectra of pure d54-DMPC and mixed d54-DMPC/DMPG (2:1 molar ratio) lipid bilayers. Dotted lines in the 31P spectra
represent deconvoluted components.
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the major component from ~45 to ~56 ppm and a smaller proportion
that exhibited an 11% reduction, which is suggestive of mixedTable 2
The effects of aurein 1.2 and caerin 1.1 on the 31P NMR lineshapea of phospholipid bilayers
Temperature 31P CSA values
d54-DMPC (ppm)
Lipid bilayer Aurein 1.2 Caeri
30 °C 45.5 37.8 38.2
















a NMR measurements are to within 1 ppm.
b (%) Relative contribution to spectral intensity.
c Isotropic peak.disordered and ordered phases such as the Pβ′ ripple phase [34,54].
Reducing the temperature of the DMPC/DMPG system resulted in a
slight broadening of the major CSA component by 1 ppm, with theabove and below the gel–ﬂuid phase transition temperature.
d54-DMPC/DMPG (2:1) (ppm)






































Fig. 3. Deuterium NMR spectra of: d54-DMPC (left) and d54-DMPC/DMPG (2:1) (right) lipid bilayers with aurein 1.2 (10:1) (1st, 3rd column) and caerin 1.1 (2nd, 4th column) at
30 °C, 20 °C and 15 °C. The spectra from the pure lipid are shown in the lower spectrum (blue) with the lipid + peptide spectrum vertically offset (black).
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(5%) evident (Fig. 2, Table 2). Although similar to the DMPC system,
the presence of the anionic lipid led to a more disordered system.
With aurein 1.2 in DMPC at 20 °C, the 2H spectra were indicative
of more restricted acyl chain motion. The major 31P CSA component
reduced in width by 34% while the minor component had an even
more signiﬁcant reduction of 61% relative to the pure lipid. Formation
of small isotropic peaks in both the 2H and 31P spectra suggested
the formation of a lipid population with severe bilayer disruption or
formation of smaller tumbling structures (Figs. 3 & 4).
The 2H spectrum of DMPCwith caerin 1.1 at 20 °C (Fig. 3), however,
retained characteristics of a ﬂuid phase bilayer, albeit with moderate
broadening, indicating the peptide may have lowered the phase transi-
tion temperature of the bilayer. No large changes were observed in the
31P CSA compared to 30 °C although the lack of the ripple/gel phases
observed in the pure lipid system (Fig. 2) further indicates the peptide
may alter the phase transition temperature of the bilayer.
An enhanced level of bilayer disruption was observed with aurein
1.2 and the DMPC/DMPG bilayer. The 2H spectrum was a mixture of
gel and isotropic phases (Fig. 3) while the 31P CSA of both components
increased signiﬁcantly to 47 and 32 ppm, respectively (Table 2). The
proportion of signal present in the minor component increased from32 to 42%, suggesting that the peptide promoted DMPG into the less
ordered phase.
The interaction of caerin 1.1 with the anionic system was more
pronounced with the formation of multiple lipid phases. The com-
plex mixed, gel, ﬂuid and isotropic 2H spectrum at 30 °C gave way
to a mainly gel phase spectrum with a small isotropic signal
(Fig. 3). A broad 54 ppm 31P CSA formed consistent with the pres-
ence of a large proportion of an immobilised/ordered lipid phase,
while a smaller proportion appeared to be ﬂuid bilayer or a more
ordered DMPG-enriched phase. Another, signiﬁcantly more disordered
phase was also present and may have been due to components from
what was previously an isotropic phase. The proportion of signal at
the isotropic chemical shift decreased from 53 to 32% suggesting that
a major fraction of the lipid was frozen into a more immobile state
and that the isotropic fraction was highly disordered lipid since the
reduction in temperature would not signiﬁcantly restrict the motion
of any small isotropically tumbling aggregates (especially since the 2H
spectrum shows the presence of gel-phase).
A further reduction in temperature to 15 °C did not cause any sig-
niﬁcant changes in the 2H or 31P spectra of the pure DMPC (Fig. 2). In
the anionic mixed lipid system, the reduction in temperature resulted
in multiple lipid phases or domains, with a small increase in the main
Fig. 4. 31P NMR spectra of DMPC (left) and DMPC/DMPG (2:1) (right) with aurein 1.2 at a 10:1 L/P ratio. Spectra were recorded at (a) 30 °C, (b) cooled to 20 °C, (c) further cooled to
15 °C, and (d) after reheated back to 30 °C. Unbroken lines represent the experimental spectra; dotted lines represent the deconvoluted components.
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~62 to ~42%. The second major component conversely experienced
a signiﬁcant (11 ppm) reduction in CSA with only a slight decrease
in fraction of the signal. The isotropic fraction increased from 5 to
15% and a third, broader CSA (47 ppm) was apparent with 12% of
the signal.
DMPC with aurein 1.2 (Figs. 3, 4c) led to fully isotropic 2H and 31P
spectra at 15 °C, indicating a major enhancement in lipid disorder or
rapidly diffusing lipid or tumbling structures. Caerin 1.1 (Fig. 3), howev-
er, did not promote an enhanced interaction with the lipid acyl chains,
which were characteristic of a gel phase. The lipid headgroup region
experienced reduced motions with the formation of an additional
broad 31P CSA (Fig. 5c) similar to the ordered/immobilised phase
observed with the pure lipid and a slight increase in the ~41 ppm CSA
observed at the preceding temperature.
For the mixed lipid system with aurein 1.2, the 2H spectrum (Fig. 3)
consisted of a mixture of a narrow isotropic signal, indicating wide-
spread bilayer disruption, and a minor residual gel phase component.
A bilayer phase was retained as well as considerably more disordered
lipid relative to the control. A large 31P isotropic phase indicated aurein
1.2 caused a signiﬁcant increase in disordered lipid or formation of small
rapidly tumbling aggregates. With caerin 1.1, a gel phase 2H spectrum,with a minor isotropic signal, and no major changes in the linewidth
of the 31P CSA indicated that the majority of the lipid was relatively
immobile and in a gel phase together with a small more disordered
population.
To investigate whether the changes in lipid bilayer structure that
occurred due to the reduction in temperature were reversible, the
samples were reheated to their original temperature. In contrast to
the freeze–thaw process during sample preparation, which takes
place quickly, this process is slower and the NMR samples were kept
for several hours at each temperature. Cycling back through the gel–
ﬂuid transition temperature to 30 °C allowed lamellar bilayer systems
to be restored, although with aurein 1.2 these were in a more disor-
dered state than initially observed. With aurein 1.2 in DMPC, the
order parameters of the upper acyl chain increased slightly, while the
lower acyl chain region was more perturbed (Fig. S1). A reduction in
resolution prevented the individual deuterated methylene peaks from
being resolved, which suggests an enhanced interaction (leading to re-
duction in T2 relaxation times) within the bilayer interior. The greatly
perturbed isotropic 31P spectrum observed at 15 °C partially reformed
into a considerably disordered bilayer phase (Fig. 4d). The original
37 ppm CSA (Table 2) was partially restored (20% of original signal)
and a smaller, more disordered bilayer phase also formed, representing
Fig. 5. 31P NMR spectra of DMPC (left) and DMPC/DMPG (2:1) (right) with caerin 1.1 at a 10:1 L/P ratio. Spectra were recorded (a) at 30 °C, (b) cooled to 20 °C, (c) further cooled to
15 °C, and (d) after reheated back to 30 °C. Unbroken lines represent the experimental spectra; dotted lines represent the deconvoluted components.
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isotropic peak comprising 55% of the signal indicates that the
temperature-induced disruptions to bilayer integrity are only partially
reversible and that the temperature cycling assists peptide insertion
into the bilayer. With caerin 1.1 in DMPC there was no signiﬁcant
change in the order parameter proﬁle (Fig. S1) and the original 31P
CSA was completely restored (Fig. 5d, Table 2), indicating that cycling
through the phase transition did not cause any substantial effect on
the interaction of the longer peptide.
For the mixed lipid system with aurein 1.2, reheating to 30 °C
resulted in partial reformation of a more disordered mixed gel and
ﬂuid bilayer phase with considerable perturbation of the upper acyl
chain segment (Table 2); which supports an enhanced surface inter-
action presumably driven by electrostatic attraction to the anionic
lipid [55]. The 31P spectrum was largely restored although the indi-
vidual CSAs were slightly broadened, indicating an increase in bilayer
order, but an additional isotropic, more disordered, component (15%)
was apparent (Table 2).
With caerin 1.1, the 2H spectrum returned to a complex mixture
of gel, isotropic and disordered lamellar bilayer (Table 2). A broad
~55 ppmordered/immobilised lipid phase togetherwith twonarrower,
37 and 25 ppm 31P CSAs,was present and the proportion of signal at theisotropic chemical shift returned close to that observed initially, as the
increase in temperature liberated some immobilised lipid.
4. Discussion
In this study, solid-state NMR and CD spectroscopywere used to ex-
amine aurein 1.2 and caerin 1.1 in PC and PC/PG membrane systems to
reﬁne our understanding of theirmode of action and lead tomore effec-
tive AMP. The secondary structure adopted by aurein 1.2 and caerin 1.1
in neutral and anionic phospholipid membranes as well as the interac-
tion with ﬂuid and gel phase lipid bilayers are discussed.
4.1. Mode of antimicrobial peptide interaction
Themoderate decrease in the 31P CSA ofDMPC at 30 °C (Table 2) ob-
servedwith both peptides togetherwith the observed changes in the 2H
order parameter proﬁles and secondary structure (Table 1) suggests a
different mode of action for each peptide. Together, the CD spectrosco-
py, 31P and 2H NMR data indicate that aurein 1.2 has a high propensity
to form an α-helix and interacts primarily with the neutral bilayer sur-
face, consistentwith previous studies [7,12,13], while the cryo-TEM and
AFM images (Figs. S3 & S4b) show a breakdown of DMPC lipid
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the neutral lipid, increased disorder about the phospholipid
headgroup and lower acyl chain region, while promoting a slight
ordering effect in the upper acyl chain, consistent with a previous
study [7]. No speciﬁc changes to the DMPC vesicles were observed
by AFM (Fig. S4c) suggesting no overall changes to bilayer integrity.
In contrast to the shorter peptide, these results are suggestive of
peptide interaction throughout the entire bilayer due to peptide
penetration.
Consistent with previous studies that emphasise the importance
of membrane charge in modulating cationic AMP–membrane interac-
tions [6,14,15,22,28,38,43,53], signiﬁcant effects were observed on
anionic phospholipid bilayers with both peptides. Aurein 1.2 had a
similar propensity to form an α-helix and perturbed the entire length
of the acyl chain region with a signiﬁcant narrowing of the DMPG CSA
component. The effect is consistent with a primarily surface interac-
tion and intercalation among the headgroup region, which would
allow greater motional ﬂexibility within the acyl chain region.
While the mode of action of aurein 1.2 broadly reﬂected that seen
with DMPC, caerin 1.1 had a more complex mode of interaction that
led to the formation of a mixture of multiple lipid phases or domains
in the anionic bilayer. Both CD and NMR showed that the peptide was
more α-helical in the presence of the anionic lipid and caused signif-
icant disruption of the lipid headgroup region and acyl chain interior,
leading to the co-existence of gel, ﬂuid and isotropic bilayer phases.
Caerin 1.1 likely inserted into the bilayer, creating lipid domains of
different acyl chain orders and inducing the formation of highly
curved regions such as those in a toroidal pore model [17,19]
(or highly curved structures as seen by AFM of vesicles on a solid sur-
face, Fig. S4f). For both peptides, the signiﬁcant interaction and for-
mation of different lipid domains imply a preferential interaction for
the anionic DMPG component.
4.2. Inﬂuence of phospholipid phase on antimicrobial peptide activity
While the mode of action of each peptide has been observed in
ﬂuid phase membranes, the interaction was shown signiﬁcantly to
differ below the phase transition temperature of the pure lipids
(~23 °C). The effect of the gel–ﬂuid phase transition was investigated
by performing the NMR measurements at 30, 20, and 15 °C and then
reheating to 30 °C.
Reducing the temperature produced a ripple phase [34] in the
DMPC bilayer, with interspersed areas of ordered and disordered
phospholipid headgroups observed by 31P NMR, while the 2H NMR
spectra were dominated by acyl chains in an ordered phase [56,57].
In the mixed lipid bilayers, however, the presence of the DMPG
permitted a greater freedom of motion in the headgroup region such
that the 31P spectrumchanged littlewith the drop in temperature, likely
due to an alteration in the electric charge allowing greater mobility and
altering the orientation of the lipid headgroups [58]. While the
headgroup region was more perturbed than for pure DMPC, the 2H
spectra were consistent with gel phase lipid acyl chains suggesting
that the disorder does not continue into the bilayer interior.
Lowering the temperature promoted a signiﬁcant enhancement of
the effect of aurein 1.2 on the neutral DMPC bilayer, while minimal
additional effect was seen with the larger caerin 1.1 (Figs. 4b & 5b).
The surface interaction of aurein 1.2 was enhanced at 20 °C, just
below the gel–ﬂuid transition of the pure lipid, and the acyl chain
interior continued to display characteristics of a ﬂuid phase, consis-
tent with AMP shifting the phase transition temperature [15]. The de-
crease in temperature may have enhanced peptide interaction due to
the formation of defects in the mixed ordered/disordered ripple
phase [29,34,35] or the more ordered acyl chains may facilitate the
interaction [59]. These results are consistent with an enhanced lytic
effect of aurein 1.2 and a related peptide, maculatin 1.1, observed
below the lipid phase transition in QCM-D and DPI studies [36,37].Whereas only aurein 1.2 showed enhanced interaction with the
neutral DMPC at 20 °C, in themixed DMPC/DMPG bilayer both peptides
did. For aurein 1.2, the lipid components became more intimately
mixed as the 31P CSA components became more equal, while broaden-
ing of the linewidth reﬂected slower lipid motions. The large isotropic
peak observed with caerin 1.1 reduced in intensity and an additional
broad CSA formed, due to slower motions at the lower temperature.
The transformation of the 2H spectrum into a mixed gel and isotropic
phase was consistent with reduced lipid dynamics.
Further reduction in temperature to 15 °C resulted in a complete
disruption of the DMPC bilayer by aurein 1.2 into small, rapidly tum-
bling or diffusing aggregates. A similar effect was evident with the
mixed lipid bilayer in which an enhanced interaction also led to for-
mation of small rapidly tumbling or diffusing lipid aggregates, al-
though a small amount of residual lamellar bilayer remained. In
both cases the manner in which the lipid bilayers were disrupted
was consistent with the carpet mechanism, with peptide interaction
enhanced at the lower temperature. In contrast, at 15 °C the larger
caerin 1.1 did not display any enhanced interaction with DMPC rela-
tive to at 20 °C, with only a general reduction of lipid motion ob-
served. This was similar to the mixed lipid system in which no
further changes were seen suggesting that the change in temperature
and phase had little effect on the activity of the larger peptide. The
enhanced effects of the smaller peptide are similar to those seen
with other membrane lytic peptides such as melittin which induces
formation of small 20–40 nm lipid discs in phospholipid bilayers
after passing through the gel–ﬂuid phase transition into the ripple
and gel phase [29,33]. A reversible transition between disc-like mi-
celles and extended bilayers occurs with temperature through the
DMPC phase transition [31] and is driven by peptide interaction
with defects formed in the gel and intermediate ripple phases.
Cryo-TEM studies conducted with the diluted NMR samples revealed
small lipid structures (Fig. S3), while AFM measurements (Fig. S4)
also showed a disruption of the membrane consistent with aurein
1.2 adopting a similar mode of action. In a similar manner the AMP,
magainin 2 [27] and maculatin 1.1 [26] also induce formation of iso-
tropic 31P NMR signals in DMPC bilayers below the phase transition.
Apart fromcaerin 1.1 in DMPC,which had aminimal interaction that
did not change with temperature cycling, each bilayer systemwas con-
siderably more perturbed when returned back to the ﬂuid phase at
30 °C. For aurein 1.2with DMPC and both peptides in themixed lipid bi-
layers, additional disorderwas present relative to the starting condition.
However, for the bilayer with aurein 1.2 a large isotropic component
was retained, suggesting that cycling through the phase transition en-
hanced themembrane disruption by the peptide. The acyl chain interior
wasmore perturbed, whichmay have been due to peptide intercalating
among the interfacial/upper acyl chain region and increasing the order
parameters while allowing more freedom of motion and reduced order
deeper in the bilayer. The mixed lipid bilayer continued to exhibit an
isotropic phase with aurein 1.2 and the lipids present were more inti-
mately mixed than before passing through the gel–liquid transition
temperature. Caerin 1.1 with the mixed bilayer continued to exhibit
characteristics of mixed gel, ﬂuid and isotropic phases when returned
to 30 °C, suggesting that the peptide promoted domain formation.
With the exception of DMPC with caerin 1.1, the slow passage
through the phase transition enhanced the peptide interaction with
the membrane.
In summary, both peptides gained signiﬁcant α-helical secondary
structure in the presence of the DMPC membrane. In the ﬂuid phase,
aurein 1.2 displayed a primary surface interaction with eukaryotic-like
bilayers, while the larger caerin 1.1 penetrated into and affected the
full length of the bilayer. Both peptides interacted in a manner which
signiﬁcantly perturbed bilayer order, but retained overall bilayer
integrity.
In the model prokaryotic-like bilayers, both peptides displayed a
preferential interaction with the anionic DMPG component. Aurein
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acyl chain interior in a manner which enhanced disorder or motional
ﬂexibility within the bilayer core. Caerin 1.1 was able to penetrate
into the bilayer interior and promoted the formation and stabilisation
of a mixture of isotropic, gel and ﬂuid phase lipid domains in a man-
ner suggestive of toroidal pore formation.
Below the phase transition of eukaryotic-like bilayers, aurein 1.2 in-
duced a complete bilayer disruption into small, rapidly tumbling lipid
aggregates, similar to the effects of melittin [29,31–33] and maculatin
1.1 [26]. Caerin 1.1, however, did not display any enhanced interaction
with the eukaryotic-like bilayer. Although a lamellar bilayer phase was
largely retained for the prokaryotic-like bilayers, together with a signif-
icant isotropic phase for caerin 1.1, a partial disruption via the carpet
mechanismwas observed with aurein 1.2. The mode of action of aurein
1.2 was enhanced relative to the ﬂuid phase and was likely driven
by the co-existence of membrane defects. Caerin 1.1 did not display
any signiﬁcantly enhanced interaction at lower temperatures. The en-
hanced effects of aurein 1.2 in the gel phase show that the role of lipid
phase and order needs to be considered when studying membrane
interactions of AMPs and suggest that the lipid chains may also play a
signiﬁcant role in the selectivity of antimicrobial peptides.
5. Conclusions
The solid-state NMR data of aurein 1.2 and caerin 1.1 with model
membranes above and below the gel–ﬂuid transition temperature
indicate that peptide activity and insertion is inﬂuenced by the phase/
order of the membrane. The lipid compositions of bacterial membranes
evolve during the growth cycle, substituting unsaturated and saturated
species and, therefore, modulating ﬂuid and gel phase properties.
Hence, understanding the peptide activity in both phases is critical in
their development as potent antibiotics in order to design AMP with
high afﬁnity and activity.
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